Matches in Nanopublications for { ?s ?p "[Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP501528.RAlSbVGtSU9KU2ugn7alH5NmFBrzLk3-P0dI36fiukYfM130_assertion description "[Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501528.RAlSbVGtSU9KU2ugn7alH5NmFBrzLk3-P0dI36fiukYfM130_provenance.
- NP501529.RAMRwPyS9gTUHzEah53j5cARjjbhZ9-e5rWpXJiEi0GQY130_assertion description "[Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501529.RAMRwPyS9gTUHzEah53j5cARjjbhZ9-e5rWpXJiEi0GQY130_provenance.